The clinical risk management as a tool to improve the quality and appropriateness of health services, in recent years has proved to conquer a central position in the politics of Clinical Governance. The main reason behind this rise is the need to contain the increasing litigation in the Jield of medical liability through instruments able to...
-
2014 (v1)PublicationUploaded on: April 14, 2023
-
2015 (v1)Publication
Intra-arterial transplantation of mesoangioblasts proved safe and partially efficacious in preclinical models of muscular dystrophy. We now report the first-in-human, exploratory, non-randomized open-label phase I-IIa clinical trial of intra-arterial HLA-matched donor cell transplantation in 5 Duchenne patients. We administered escalating doses...
Uploaded on: April 14, 2023